VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
UTHR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
UTHRUnited Therapeutics Corporation
$544.92$23.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksUTHRQuarterly Financials

United Therapeutics Corporation (UTHR) Quarterly Financials

120+ quarters historyFree accessUpdated daily

United Therapeutics Corporation (UTHR) quarterly income statement — complete revenue, gross profit & net income history

UTHR Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue781.5M790.2M799.5M798.6M794.4M735.9M748.9M714.9M677.7M614.7M609.4M596.5M506.9M491.5M516M466.9M461.9M415.2M444.7M446.5M
Revenue Growth %-1.62%7.38%6.76%11.71%17.22%19.72%22.89%19.85%33.7%25.07%18.1%27.76%9.74%18.38%16.03%4.57%21.84%7.87%17%23.34%
Cost of Goods Sold133.4M103.4M100.9M87.6M92.5M75.9M83.1M77.8M72.9M71M70.1M64.1M52.3M55.9M37.2M29.7M25.9M34.6M27.7M37.2M
COGS % of Revenue17.07%13.09%12.62%10.97%11.64%10.31%11.1%10.88%10.76%11.55%11.5%10.75%10.32%11.37%7.21%6.36%5.61%8.33%6.23%8.33%
Gross Profit648.1M686.8M698.6M711M701.9M660M665.8M637.1M604.8M543.7M539.3M532.4M454.6M435.6M478.8M437.2M436M380.6M417M409.3M
Gross Margin %82.93%86.91%87.38%89.03%88.36%89.69%88.9%89.12%89.24%88.45%88.5%89.25%89.68%88.63%92.79%93.64%94.39%91.67%93.77%91.67%
Gross Profit Growth %-7.66%4.06%4.93%11.6%16.05%21.39%23.46%19.67%33.04%24.82%12.64%21.77%4.27%14.45%14.82%6.82%22.44%8.71%17.1%21.78%
Operating Expenses322.3M329.3M309.3M346.5M319.1M302.3M322.7M317.2M248.5M283.6M212.3M219M170.2M260M164.5M235.4M148M210.8M188.3M187.1M
OpEx % of Revenue41.24%41.67%38.69%43.39%40.17%41.08%43.09%44.37%36.67%46.14%34.84%36.71%33.58%52.9%31.88%50.42%32.04%50.77%42.34%41.9%
Selling, General & Admin184.1M189.8M181.8M190.8M170.1M162.5M219.2M177.6M144.4M132.2M127.6M130M87.3M166.1M98.4M141.5M79M127.9M109.1M112.8M
SG&A % of Revenue23.56%24.02%22.74%23.89%21.41%22.08%29.27%24.84%21.31%21.51%20.94%21.79%17.22%33.79%19.07%30.31%17.1%30.8%24.53%25.26%
Research & Development138.2M139.5M127.5M134M149M133.8M103.5M139.6M104.1M151.4M84.7M89M82.9M93.9M66.1M93.9M69M82.9M79.2M74.3M
R&D % of Revenue17.68%17.65%15.95%16.78%18.76%18.18%13.82%19.53%15.36%24.63%13.9%14.92%16.35%19.1%12.81%20.11%14.94%19.97%17.81%16.64%
Other Operating Expenses0001000K01000K00000-600K00000000
Operating Income325.8M357.5M389.3M364.5M382.8M357.7M343.1M319.9M356.3M260.1M327M313.4M284.4M175.6M314.3M201.8M288M169.8M228.7M222.2M
Operating Margin %41.69%45.24%48.69%45.64%48.19%48.61%45.81%44.75%52.57%42.31%53.66%52.54%56.11%35.73%60.91%43.22%62.35%40.9%51.43%49.76%
Operating Income Growth %-14.89%-0.06%13.47%13.94%7.44%37.52%4.92%2.07%25.28%48.12%4.04%55.3%-1.25%3.42%37.43%-9.18%544.44%160.03%3.44%58.15%
EBITDA348.4M380.3M411.2M385.6M348.2M377.4M362.2M338.6M371.3M273.8M340.3M326.3M297.7M188.8M327.2M214.5M300.5M182.4M241.1M234.6M
EBITDA Margin %44.58%48.13%51.43%48.28%43.83%51.28%48.36%47.36%54.79%44.54%55.84%54.7%58.73%38.41%63.41%45.94%65.06%43.93%54.22%52.54%
EBITDA Growth %0.06%0.77%13.53%13.88%-6.22%37.84%6.44%3.77%24.72%45.02%4%52.12%-0.93%3.51%35.71%-8.57%674.57%132.65%3.52%53.23%
D&A (Non-Cash Add-back)22.6M22.8M21.9M21.1M-34.6M19.7M19.1M18.7M15M13.7M13.3M12.9M13.3M13.2M12.9M12.7M12.5M12.6M12.4M12.4M
EBIT325.8M447.1M441M415.7M417.4M404.4M398.7M319.9M411.9M310.5M327M313.4M305.7M184.9M321.7M156.8M288M169.2M209M222.2M
Net Interest Income38.8M40.1M43.4M44M45M41.4M39.7M34.6M40.5M35.9M29.7M22.4M15.4M8.5M4.1M600K-400K-500K-800K-700K
Interest Income41.8M43.2M46.4M51.3M51.1M49.3M49.8M46.2M53.8M51M45.3M37.2M29.2M20.8M13.3M6.8M4.3M4.2M3.8M4M
Interest Expense3M3.1M3M7.3M6.1M7.9M10.1M11.6M13.3M15.1M15.6M14.8M13.8M12.3M9.2M6.2M4.7M4.7M4.6M4.7M
Other Income/Expense-7.5M86.5M48.7M43.9M40.7M38.8M45.5M35.4M42.3M35.3M24.8M21.8M7.5M3.2M-1.8M-51.2M20.7M-29.3M-24.3M-5.7M
Pretax Income318.3M444M438M408.4M423.5M396.5M388.6M355.3M398.6M295.4M351.8M335.2M291.9M178.8M312.5M150.6M308.7M140.5M204.4M216.5M
Pretax Margin %40.73%56.19%54.78%51.14%53.31%53.88%51.89%49.7%58.82%48.06%57.73%56.19%57.59%36.38%60.56%32.26%66.83%33.84%45.96%48.49%
Income Tax43.4M79.7M99.3M98.9M101.3M95.2M79.5M77.2M92M78.3M84.2M76M51M46.7M73.2M34.6M68.8M28.3M41.7M43.9M
Effective Tax Rate %13.63%17.95%22.67%24.22%23.92%24.01%20.46%21.73%23.08%26.51%23.93%22.67%17.47%26.12%23.42%22.97%22.29%20.14%20.4%20.28%
Net Income274.9M364.3M338.7M309.5M322.2M301.3M309.1M278.1M306.6M217.1M267.6M259.2M240.9M132.1M239.3M116M239.9M112.2M162.7M172.6M
Net Margin %35.18%46.1%42.36%38.76%40.56%40.94%41.27%38.9%45.24%35.32%43.91%43.45%47.52%26.88%46.38%24.84%51.94%27.02%36.59%38.66%
Net Income Growth %-14.68%20.91%9.58%11.29%5.09%38.78%15.51%7.29%27.27%64.35%11.83%123.45%0.42%17.74%47.08%-32.79%747.7%13.56%-4.96%61.16%
Net Income (Continuing)274.9M364.3M338.7M309.5M322.2M301.3M309.1M278.1M306.6M217.1M267.6M259.2M240.9M132.1M239.3M116M239.9M112.2M162.7M172.6M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)5.827.667.166.416.636.196.395.856.174.365.385.244.862.674.912.415.032.353.423.65
EPS Growth %-12.22%23.75%12.05%9.57%7.46%41.97%18.77%11.64%26.95%63.3%9.57%117.43%-3.38%13.62%43.57%-33.97%724.59%7.31%-10.94%51.45%
EPS (Basic)6.328.367.736.867.186.746.936.266.524.625.715.535.202.884.912.415.032.493.623.85
Diluted Shares Outstanding47.2M47.9M47.3M48.3M48.6M48.7M48.4M47.5M49.7M49.8M49.7M49.5M49.6M49.4M48.7M48.1M47.7M47.8M47.6M47.3M
Basic Shares Outstanding43.5M44.3M43.8M45.1M44.9M45.2M44.6M44.4M47M47M46.9M46.9M46.3M45.8M48.7M48.1M47.69M45.1M44.9M44.8M
Dividend Payout Ratio--------------------